Literature DB >> 23255745

Quantitatively defining washout in hepatocellular carcinoma.

Yueyi I Liu1, Lewis K Shin, R Brooke Jeffrey, Aya Kamaya.   

Abstract

OBJECTIVE: Washout on delayed phase (or equilibrium phase) imaging of an arterially hyperenhancing lesion is an excellent predictor of hepatocellular carcinoma (HCC). The purpose of our study was to quantitatively define washout in pathologically proven HCC. A quantitative definition of HCC may minimize interobserver variability and facilitate more accurate diagnosis.
MATERIALS AND METHODS: We identified 47 liver lesions that were hyperenhancing in the arterial phase from 24 patients who underwent triphasic MDCT as part of preoperative evaluation for liver transplantation. All HCCs were pathologically proven. Regions of interest were obtained of lesions and areas of adjacent liver on arterial, portal venous, and delayed phase images. Enhancement profiles were assessed by three radiologists.
RESULTS: Of the 47 hypervascular lesions, 14 HCCs were identified. There was a statistically significant difference in percentage attenuation ratio (defined as 100 × ratio of attenuation of adjacent liver to that of the lesion) between lesions that were HCC (median percentage attenuation ratio, 121) and those that were not (median percentage attenuation ratio, 101) on delayed phase. Percentage attenuation ratio ≥ 107 on delayed phase imaging achieved maximal sensitivity (100%) with good specificity (75.8%), positive predictive value (PPV) (63.6%), and negative predictive value (NPV) (100%) in HCC detection. Percentage attenuation ratio also correlated well with radiologists' assessments of enhancement profiles of lesions (multinomial logistic regression McFadden R(2), 0.72; chi-square p, < 0.01).
CONCLUSION: Our analysis of simple CT attenuation measurements indicates that percentage attenuation ratio offers excellent sensitivity, specificity, PPV, and NPV for HCC detection and very good correlation with radiologists' assessments of washout.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23255745     DOI: 10.2214/AJR.11.7171

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

Review 1.  LI-RADS 2017: An update.

Authors:  Ania Z Kielar; Victoria Chernyak; Mustafa R Bashir; Richard K Do; Kathryn J Fowler; Donald G Mitchell; Milena Cerny; Khaled M Elsayes; Cynthia Santillan; Aya Kamaya; Yuko Kono; Claude B Sirlin; An Tang
Journal:  J Magn Reson Imaging       Date:  2018-04-06       Impact factor: 4.813

2.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

Review 3.  Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.

Authors:  Sonal Krishan; Radha K Dhiman; Navin Kalra; Raju Sharma; Sanjay S Baijal; Anil Arora; Ajay Gulati; Anu Eapan; Ashish Verma; Shyam Keshava; Amar Mukund; S Deva; Ravi Chaudhary; Karthick Ganesan; Sunil Taneja; Ujjwal Gorsi; Shivanand Gamanagatti; Kumble S Madhusudan; Pankaj Puri; Shallini Govil; Manav Wadhavan; Sanjiv Saigal; Ashish Kumar; Shallini Thapar; Ajay Duseja; Neeraj Saraf; Anubhav Khandelwal; Sumit Mukhopadyay; Ajay Gulati; Nitin Shetty; Nipun Verma
Journal:  J Clin Exp Hepatol       Date:  2019-08-06

4.  Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans.

Authors:  F Edward Boas; Aya Kamaya; Bao Do; Terry S Desser; Christopher F Beaulieu; Shreyas S Vasanawala; Gloria L Hwang; Daniel Y Sze
Journal:  J Digit Imaging       Date:  2015-04       Impact factor: 4.056

Review 5.  Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Authors:  An Tang; Mustafa R Bashir; Michael T Corwin; Irene Cruite; Christoph F Dietrich; Richard K G Do; Eric C Ehman; Kathryn J Fowler; Hero K Hussain; Reena C Jha; Adib R Karam; Adrija Mamidipalli; Robert M Marks; Donald G Mitchell; Tara A Morgan; Michael A Ohliger; Amol Shah; Kim-Nhien Vu; Claude B Sirlin
Journal:  Radiology       Date:  2017-11-21       Impact factor: 11.105

Review 6.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

7.  Kinetic analysis of dynamic (11)C-acetate PET/CT imaging as a potential method for differentiation of hepatocellular carcinoma and benign liver lesions.

Authors:  Li Huo; Jinxia Guo; Yonghong Dang; Jinqiao Lv; Youjing Zheng; Fang Li; Qingguo Xie; Xiaoyuan Chen
Journal:  Theranostics       Date:  2015-01-21       Impact factor: 11.556

Review 8.  Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 1.

Authors:  Miguel Ramalho; António P Matos; Mamdoh AlObaidy; Fernanda Velloni; Ersan Altun; Richard C Semelka
Journal:  Radiol Bras       Date:  2017 Jan-Feb

Review 9.  Computed Tomography Techniques, Protocols, Advancements, and Future Directions in Liver Diseases.

Authors:  Naveen M Kulkarni; Alice Fung; Avinash R Kambadakone; Benjamin M Yeh
Journal:  Magn Reson Imaging Clin N Am       Date:  2021-08       Impact factor: 1.376

10.  Quantitative assessment of washout in hepatocellular carcinoma using MRI.

Authors:  Roman Kloeckner; Daniel Pinto Dos Santos; Karl-Friedrich Kreitner; Anne Leicher-Düber; Arndt Weinmann; Jens Mittler; Christoph Düber
Journal:  BMC Cancer       Date:  2016-09-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.